Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




US Project Adds Extensive Range of Genetic, Health Information to Online Database

By LabMedica International staff writers
Posted on 17 Mar 2014
Genetic data related to medical information on a diverse group of more than 78,000 individuals will now be accesible to researchers, enabling comprehensive research into many diseases and conditions. More...


The data, from one of the US largest and most diverse genomics projects called the Genetic Epidemiology Research on Aging (GERA), have just been made available to qualified researchers through the database of Genotypes and Phenotypes (dbGaP), an online genetics database of the US National Institutes of Health (Bethesda, MD, USA).

The GERA cohort, with an average age of 63, was developed collaboratively by Kaiser Permanente (Oakland, CA, USA) and the University of California, San Francisco (UCSF; USA). The addition of the data to dbGaP was made possible with USD 24.9 million in support from the US National Institute on Aging (NIA; Bethesda, MD, USA), the US National Institute of Mental Health, and the Office of the Director, all at NIH. Catherine Schaefer, PhD, of Kaiser Permanente Northern California and Neil Risch, PhD, of UCSF are co-lead investigators for GERA.

“Data from this immense and ethnically diverse population will be a tremendous resource for science,” said NIH director Francis S. Collins, MD, PhD. “It offers the opportunity to identify potential genetic risks and influences on a broad range of health conditions, particularly those related to aging.”

The GERA cohort is part of the Research Program on Genes, Environment, and Health (RPGEH), which includes more than 430,000 adult members of the Kaiser Permanente Northern California system. Data from this larger group include electronic medical records (EMRs), behavioral and demographic information from surveys, and saliva samples from 200,000 participants obtained with informed consent for genomic and other analyses.

“The GERA cohort has the largest number of people, of any age, with data in dbGaP,” said NIA director Richard J. Hodes, MD. “Federal funds were used to develop new approaches to genomics for this project, and I’m pleased that the data are now ready in dbGaP for researchers’ use. I look forward to new insights that such a unique resource might offer for better health with age.”

The genetic data in the GERA cohort translates into more than 55 billion bits of genetic data. Using newly developed techniques, the researchers conducted genome-wide scans to rapidly identify single nucleotide polymorphisms (SNPs) in the genomes of the people in the GERA cohort. These data will form the foundation of genome-wide association studies (GWAS) that can search throughout the hundreds of thousands to millions of SNPs simultaneously. The RPGEH then combined the genetic data with information derived from Kaiser Permanente’s comprehensive longitudinal EMRs, as well as extensive survey data on participants’ health habits and backgrounds, providing researchers with an unparalleled research resource.

In addition to diseases and conditions traditionally associated with aging, such as cardiovascular disease, cancer, and osteoarthritis, researchers can explore the potential genetic underpinnings of a variety of diseases that affect people in adulthood, including depression, insomnia, diabetes, certain eye diseases and many others representing a variety of disease domains. Researchers will also be able to use the database to confirm or disprove other studies that use data from relatively small numbers of people, as well as to increase the size and strength of their samples by adding participants from GERA to meta-analyses. The large cohort will also serve as a reference source of controls that researchers can compare to individuals with different disorders that they have examined.

“An exciting aspect of this dataset is that it will be updated and refreshed,” noted Winifred Rossi, deputy director of NIA’s Division of Geriatrics and Clinical Gerontology and program officer for the project. “As information is added to the Kaiser-UCSF database, the dbGaP database will also be updated.”

dbGaP was developed and is managed by the US National Center for Biotechnology Information, a division of the National Library of Medicine at NIH. Investigators who are interested in applying for access to this database should follow the procedures on the dbGaP website. Specific information on the data can be found online (Please see related Links below).

The NIA leads the US effort conducting and supporting research on aging and the health and well-being of older people. The Institute’s scientific program’s goal is to further understand the processes of aging and to lengthen the healthy, active years of life.

Related Links:

US National Institutes of Health
Genotypes and Phenotypes Database
US National Institute on Aging



Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Alcohol Testing Device
Dräger Alcotest 7000
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.